311 related articles for article (PubMed ID: 30385631)
1. Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.
Banerjee NS; Moore DW; Broker TR; Chow LT
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11138-E11147. PubMed ID: 30385631
[TBL] [Abstract][Full Text] [Related]
2. HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures.
Kho EY; Wang HK; Banerjee NS; Broker TR; Chow LT
Proc Natl Acad Sci U S A; 2013 May; 110(19):7542-9. PubMed ID: 23572574
[TBL] [Abstract][Full Text] [Related]
3. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes.
Wang HK; Duffy AA; Broker TR; Chow LT
Genes Dev; 2009 Jan; 23(2):181-94. PubMed ID: 19131434
[TBL] [Abstract][Full Text] [Related]
4. Targeting DNA Damage Response as a Strategy to Treat HPV Infections.
Banerjee NS; Moore D; Parker CJ; Broker TR; Chow LT
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683862
[TBL] [Abstract][Full Text] [Related]
5. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.
Flores ER; Allen-Hoffmann BL; Lee D; Lambert PF
J Virol; 2000 Jul; 74(14):6622-31. PubMed ID: 10864676
[TBL] [Abstract][Full Text] [Related]
6. Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.
Banerjee NS; Genovese NJ; Noya F; Chien WM; Broker TR; Chow LT
J Virol; 2006 Jul; 80(13):6517-24. PubMed ID: 16775338
[TBL] [Abstract][Full Text] [Related]
7. NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions.
Banerjee NS; Moore DW; Wang HK; Broker TR; Chow LT
Antiviral Res; 2019 Oct; 170():104559. PubMed ID: 31319090
[No Abstract] [Full Text] [Related]
8. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
Liu Y; McKalip A; Herman B
J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes.
Jian Y; Schmidt-Grimminger DC; Chien WM; Wu X; Broker TR; Chow LT
Oncogene; 1998 Oct; 17(16):2027-38. PubMed ID: 9798674
[TBL] [Abstract][Full Text] [Related]
10. Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters.
Xargay-Torrent S; López-Guerra M; Saborit-Villarroya I; Rosich L; Campo E; Roué G; Colomer D
Clin Cancer Res; 2011 Jun; 17(12):3956-68. PubMed ID: 21652541
[TBL] [Abstract][Full Text] [Related]
11. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
[TBL] [Abstract][Full Text] [Related]
13. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
15. Roles for E1-independent replication and E6-mediated p53 degradation during low-risk and high-risk human papillomavirus genome maintenance.
Murakami I; Egawa N; Griffin H; Yin W; Kranjec C; Nakahara T; Kiyono T; Doorbar J
PLoS Pathog; 2019 May; 15(5):e1007755. PubMed ID: 31083694
[TBL] [Abstract][Full Text] [Related]
16. STAT-5 Regulates Transcription of the Topoisomerase IIβ-Binding Protein 1 (TopBP1) Gene To Activate the ATR Pathway and Promote Human Papillomavirus Replication.
Hong S; Cheng S; Iovane A; Laimins LA
mBio; 2015 Dec; 6(6):e02006-15. PubMed ID: 26695634
[TBL] [Abstract][Full Text] [Related]
17. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
18. IFN-β antiproliferative effect and miRNA regulation in Human Papilloma Virus E6- and E7-transformed keratinocytes.
Chiantore MV; Mangino G; Iuliano M; Zangrillo MS; De Lillis I; Vaccari G; Accardi R; Tommasino M; Fiorucci G; Romeo G
Cytokine; 2017 Jan; 89():235-238. PubMed ID: 26748726
[TBL] [Abstract][Full Text] [Related]
19. The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair.
Dai Y; Chen S; Kmieciak M; Zhou L; Lin H; Pei XY; Grant S
Mol Cancer Ther; 2013 Jun; 12(6):878-89. PubMed ID: 23536721
[TBL] [Abstract][Full Text] [Related]
20. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
Münger K; Scheffner M; Huibregtse JM; Howley PM
Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
